首页|冠心舒通胶囊联合单硝酸异山梨酯预防急性心肌梗死患者PCI术后再灌注心律失常的效果

冠心舒通胶囊联合单硝酸异山梨酯预防急性心肌梗死患者PCI术后再灌注心律失常的效果

扫码查看
目的:观察冠心舒通胶囊联合单硝酸异山梨酯预防急性心肌梗死(AMI)患者经皮冠状动脉介入治疗(PCI)术后再灌注心律失常(RA)的效果.方法:选取 2020 年 9 月至 2022 年 9 月该院收治的 86 例行PCI术的AMI患者进行前瞻性研究,按随机数字表法将其分为对照组与研究组各 43 例.对照组采用单硝酸异山梨酯片治疗,研究组在对照组基础上联合冠心舒通胶囊治疗.比较两组治疗前后心肌损伤标志物[肌酸激酶同工酶(CK-MB)、N端脑钠肽前体(NT-proBNP)、肌钙蛋白I(cTnI)]水平、炎性指标[白细胞介素-6(IL-6)、超敏C反应蛋白(hs-CRP)、半乳糖凝集素-3(Gal-3)]水平、RA发生率和不良反应发生率.结果:治疗后,两组CK-MB、NT-proBNP、cTnI水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组IL-6、hs-CRP、Gal-3 水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);研究组RA发生率低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:冠心舒通胶囊联合单硝酸异山梨酯应用于PCI术后AMI患者可降低心肌损伤标志物水平、炎性指标水平和RA发生率,其效果优于单纯单硝酸异山梨酯片治疗.
Effects of Guanxin Shutong capsules combined with Isosorbide mononitrate on prevention of reperfusion arrhythmia after PCI in patients with acute myocardial infarction
Objective:To observe effects of Guanxin Shutong capsules combined with Isosorbide mononitrate on prevention of reperfusion arrhythmia(RA)after percutaneous coronary intervention(PCI)in patients with acute myocardial infarction(AMI).Methods:A prospective study was conducted on 86 patients with AMI who underwent PCI in this hospital from September 2020 to September 2022.According to the random number table method,they were divided into control group and study group,43 cases in each group.The control group was treated with Isosorbide mononitrate tablets,while the study group was treated with Guanxin Shutong capsules on the basis of that of the control group.The levels of myocardial injury markers[creatine kinase isoenzyme(CK-MB),N-terminal pro-brain natriuretic peptide(NT-proBNP),troponin I(cTnI)]and inflammatory factors[interleukin-6(IL-6),high-sensitivity C-reactive protein(hs-CRP),galectin-3(Gal-3)],the incidence of RA,and the incidence of adverse reactions were compared between the two groups before and after the treatment.Results:After the treatment,the levels of CK-MB,NT-proBNP and cTnI in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).The levels of IL-6,hs-CRP and Gal-3 in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).The incidence of RA in the study group was lower than that in the control group,the difference was statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Guanxin Shutong capsules combined with Isosorbide mononitrate can reduce the levels of myocardial injury markers and inflammatory factors and the incidence of RA in the patients with AMI after PCI.Moreover,it is superior to single Isosorbide mononitrate tablets treatment.

Acute myocardial infarctionGuanxin Shutong capsulesIsosorbide mononitrateReperfusion arrhythmiaMyocardial injury markerInflammatory factor

王瑶

展开 >

丰城市人民医院心血管内科二病区,江西 宜春 331100

急性心肌梗死 冠心舒通胶囊 单硝酸异山梨酯 再灌注心律失常 心肌损伤标志物 炎性指标

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(8)
  • 14